Brief Profile

Diss Brief Profile

The Brief Profile summarizes the non-confidential data on substances as it is held in the databases of the European Chemicals Agency (ECHA), including data provided by third parties. The Brief Profile is automatically generated; note that it does not currently distinguish between harmonised classification and minimum classification; information requirements under different legislative frameworks may therefore not be fully up to date or complete. For accuracy reasons, substance manufacturers and imports have the responsibility to consult official sources, e.g. the electronic edition of the Official Journal of the European Union.
This Brief Profile is covered by the ECHA Legal Notice.

Substance Description

Substance identity

  • EC / List name:
  • IUPAC name: octapotassium octasodium 7-amino-4-hydroxy-3,8-bis(2-{2-sulfonato-4-[2-(sulfonatooxy)ethanesulfonyl]phenyl}diazen-1-yl)naphthalene-2-sulfonate 7-amino-4-hydroxy-3,8-bis(2-{4-[2-(sulfonatooxy)ethanesulfonyl]phenyl}diazen-1-yl)naphthalene-2-sulfonate 7-amino-4-hydroxy-3-(2-{2-sulfonato-4-[2-(sulfonatooxy)ethanesulfonyl]phenyl}diazen-1-yl)-8-(2-{4-[2-(sulfonatooxy)ethanesulfonyl]phenyl}diazen-1-yl)naphthalene-2-sulfonate 7-amino-4-hydroxy-8-(2-{2-sulfonato-4-[2-(sulfonatooxy)ethanesulfonyl]phenyl}diazen-1-yl)-3-(2-{4-[2-(sulfonatooxy)ethanesulfonyl]phenyl}diazen-1-yl)naphthalene-2-sulfonate
  • Substance names and other identifiers
EC / List no.:
429-070-4
CAS no.:
214362-06-8
Index number:
611-144-00-4
Molecular formula:
C104H84K8N20Na8O76S24
SMILES:
[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].NC1=CC=C2C(O)=C(N=NC3=CC=C(C=C3)S(=O)(=O)CCOS([O-])(=O)=O)C(=CC2=C1N=NC1=CC=C(C=C1)S(=O)(=O)CCOS([O-])(=O)=O)S([O-])(=O)=O.NC1=CC=C2C(O)=C(N=NC3=CC=C(C=C3S([O-])(=O)=O)S(=O)(=O)CCOS([O-])(=O)=O)C(=CC2=C1N=NC1=CC=C(C=C1)S(=O)(=O)CCOS([O-])(=O)=O)S([O-])(=O)=O.NC1=CC=C2C(O)=C(N=NC3=CC=C(C=C3)S(=O)(=O)CCOS([O-])(=O)=O)C(=CC2=C1N=NC1=C(C=C(C=C1)S(=O)(=O)CCOS([O-])(=O)=O)S([O-])(=O)=O)S([O-])(=O)=O.NC1=CC=C2C(O)=C(N=NC3=CC=C(C=C3S([O-])(=O)=O)S(=O)(=O)CCOS([O-])(=O)=O)C(=CC2=C1N=NC1=C(C=C(C=C1)S(=O)(=O)CCOS([O-])(=O)=O)S([O-])(=O)=O)S([O-])(=O)=O
InChI:
InChI=1S/C26H25N5O22S7.2C26H25N5O19S6.C26H25N5O16S5.8K.8Na/c27-18-4-3-16-17(24(18)30-28-19-5-1-14(11-21(19)56(37,38)39)54(33,34)9-7-52-59(46,47)48)13-23(58(43,44)45)25(26(16)32)31-29-20-6-2-15(12-22(20)57(40,41)42)55(35,36)10-8-53-60(49,50)51;27-20-7-6-18-19(24(20)30-29-21-8-5-17(13-22(21)53(37,38)39)52(35,36)12-10-50-56(46,47)48)14-23(54(40,41)42)25(26(18)32)31-28-15-1-3-16(4-2-15)51(33,34)11-9-49-55(43,44)45;27-20-7-6-18-19(24(20)30-28-15-1-3-16(4-2-15)51(33,34)11-9-49-55(43,44)45)14-23(54(40,41)42)25(26(18)32)31-29-21-8-5-17(13-22(21)53(37,38)39)52(35,36)12-10-50-56(46,47)48;27-22-10-9-20-21(24(22)30-28-16-1-5-18(6-2-16)48(33,34)13-11-46-51(40,41)42)15-23(50(37,38)39)25(26(20)32)31-29-17-3-7-19(8-4-17)49(35,36)14-12-47-52(43,44)45;;;;;;;;;;;;;;;;/h1-6,11-13,32H,7-10,27H2,(H,37,38,39)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51);2*1-8,13-14,32H,9-12,27H2,(H,37,38,39)(H,40,41,42)(H,43,44,45)(H,46,47,48);1-10,15,32H,11-14,27H2,(H,37,38,39)(H,40,41,42)(H,43,44,45);;;;;;;;;;;;;;;;/q;;;;16*+1/p-16
Type of substance:
Multi constituent substance
Origin:
Organic
Registered compositions:
10
Of which contain:
0 impurities relevant for classification
0 additives relevant for classification
Substance Listed:
ELINCS (European LIst of Notified Chemical Substances) List

Hazard classification & labelling

Danger! According to the harmonised classification and labelling (ATP01) approved by the European Union, this substance causes serious eye damage.

Breakdown of all 18 C&L notifications submitted to ECHA

Eye Dam. 1 H318 Harmonised Classification
Not Classified
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

https://www.echa.europa.eu/o/diss-blank-theme/images/cnl/graph/tick.png Harmonised Classification

https://www.echa.europa.eu/o/diss-blank-theme/images/cnl/graph/Reach.png REACH registration dossiers notifications

https://www.echa.europa.eu/o/diss-blank-theme/images/cnl/graph/CLP.png CLP notifications

Properties of concern

Regulatory context

Registration, Evaluation, Authorisation & Restriction of Chemicals (REACH)

Registration
Pre-registration:
Substance pre-registered under REACH.
Registration:
This substance has 8 active registrations under REACH, 1 Joint Submission(s) and 1 Individual Submission(s).
Please see Registrants/Suppliers details.
Evaluation
Dossier Evaluation:
Registration dossiers submitted to ECHA for this substance have been evaluated under REACH.
Substance Evaluation:
Authorisation
Candidate List:
Annex XIV (Authorisation List):
Restriction
Annex XVII (Restriction List):

Persistent Organic Pollutants Regulation (POPs)

List of substances subject to the POPs Regulation:
List of substances proposed as POPs:

Classification Labelling & Packaging (CLP)

Harmonised C&L:
A European Union Harmonised Classification & Labelling has been assigned to this substance.
Seveso Annex I:
Notified C&L:
Classification & Labelling has been notified by industry to ECHA for this substance.

Biocidal Products Regulation (BPR)

Active Substance:
Biocidal Products:

Prior Informed Consent (PIC)

Annex I:
Annex V:

European Union Observatory for Nanomaterials (EUON)

EUON:

About this substance

This substance is registered under the REACH Regulation and is manufactured in and / or imported to the European Economic Area, at ≥ 100 tonnes per annum.

This substance is used by consumers, in articles, by professional workers (widespread uses), in formulation or re-packing and at industrial sites.

This substance is used in the following products: textile treatment products and dyes.

Other release to the environment of this substance is likely to occur from: indoor use.

This substance is used in the following activities or processes at workplace: calendering operations and the low energy manipulation of substances bound in materials or articles.

Release to the environment of this substance can occur from industrial use: industrial abrasion processing with low release rate (e.g. cutting of textile, cutting, machining or grinding of metal) and of articles where the substances are not intended to be released and where the conditions of use do not promote release. Other release to the environment of this substance is likely to occur from: indoor use in long-life materials with low release rate (e.g. flooring, furniture, toys, construction materials, curtains, foot-wear, leather products, paper and cardboard products, electronic equipment) and outdoor use in long-life materials with low release rate (e.g. metal, wooden and plastic construction and building materials).

This substance can be found in products with material based on: fabrics, textiles and apparel (e.g. clothing, mattress, curtains or carpets, textile toys), fabrics, textiles and apparel used for large surface area articles (e.g. construction and building materials used on the floor or walls: carpets, rugs, tapestries), fabrics, textiles and apparel used for toys and other articles intended for children’s use (e.g. stuffed toys, blankets, comfort objects), fabrics, textiles and apparel used for packaging (excluding food packaging), fabrics, textiles and apparel used for furniture & furnishings, including furniture coverings (e.g. sofa covers, car seat covers, fabric chair, hammock), fabrics, textiles and apparel used for articles with intense direct dermal (skin) contact during normal use (e.g. clothing, shirts, pants, shorts) and fabrics, textiles and apparel used for bedding and mattresses articles with intense direct dermal (skin) contact during normal use (e.g. blankets, sheets).

This substance is used in the following products: textile treatment products and dyes.

This substance is used for the manufacture of: textile, leather or fur.

This substance is used in the following activities or processes at workplace: transfer of chemicals, treatment of articles by dipping and pouring, mixing in open batch processes, transfer of substance into small containers, roller or brushing applications and the low energy manipulation of substances bound in materials or articles.

Other release to the environment of this substance is likely to occur from: indoor use.

This substance is used in the following products: textile treatment products and dyes, laboratory chemicals and inks and toners.

This substance is used in the following activities or processes at workplace: transfer of chemicals, transfer of substance into small containers, mixing in open batch processes and laboratory work.

Release to the environment of this substance can occur from industrial use: formulation of mixtures.

This substance is used in the following products: textile treatment products and dyes and inks and toners.

This substance is used for the manufacture of: textile, leather or fur.

This substance is used in the following activities or processes at workplace: transfer of chemicals, transfer of substance into small containers, treatment of articles by dipping and pouring, calendering operations, roller or brushing applications, mixing in open batch processes, laboratory work and the low energy manipulation of substances bound in materials or articles.

Release to the environment of this substance can occur from industrial use: in the production of articles.

ECHA has no public registered data on the use of this substance in activities or processes at the workplace.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

Precautions for using this substance have been recommended by its registrants under REACH, as follows:

Prevention statements

When handling this substance: wear protective gloves and/or clothing, and eye and/or face protection as specified by manufacturer/supplier.

Response statements

In case of incident: Immediately call a poison center or doctor/physician. If in eyes: rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do – continue rinsing.

Guidance on the safe use of the substance provided by manufacturers and importers of this substance.

Registrants/suppliers

  • ChAR Consultancy EOOD, Kırdjali bulvard Bulgaria 37, blok 51 6600 Kırdjali Kırdjali Bulgaria
  • DyStar Colours Distribution GmbH, Am Prime-Parc 12 65479 Raunheim Germany
  • FIERATEX S.A., Nea Santa 61100 Kilkis Greece
  • Former NONS notifier unknown to ECHA - Contact the relevant French competent national authority., null
  • Huntsman Textile Effects (Germany) GmbH, Rehlinger Str. 1 D-86462 Langweid a.Lech Germany
  • Luxcontrol S.A. (OR45), 1, Avenue des Terres Rouges 4004 Esch-sur-Alzette Luxembourg
  • Only representative (No publishable name), null
  • TEXTILCOLOR GmbH (OR), Schlossgartenstrasse 2 72793 Pfullingen Baden-Wuerttemberg Germany

Substance names and other identifiers

7-Amino-3,8-bis-(4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo)-4-hydroxynaphthalene-2-sulfonic acid, na/k salt
SCARLET DER 8107
Other
7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt
SCARLET DER 8107
C&L Inventory
7-amino-3,8-bis-[[]4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt
SCARLET DER 8107
Other
7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt
SCARLET DER 8107
C&L Inventory
7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt
SCARLET DER 8107
C&L Inventory
reaction mas of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt; 7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt
SCARLET DER 8107
CAD - Chemical Agents Directive, Art. 2(b)(i) - Hazardous Agents, Construction Product Regulation - Annex I (3) - Hazardous Substances, Construction Product Regulation - Art. 6(5) - SDS and Declaration, EU Ecolabels - Restrictions for Hazardous Substances/Mixtures, Active Implantable Medical Devices Directive - Hazardous Substances, In Vitro Diagnostic Medical Devices Directive - Hazardous Substances, , Marine Environmental Policy Framework Directive - Hazardous Substances, Medical Devices Directive - Hazardous Substances, Medical Devices Regulation - Hazardous Substances, General Product Safety Directive - Hazardous Substances, Workplace Signs - minimum requirements & signs on containers and pipes, Safety and Health of Workers at Work Directive - Hazardous Substances, Waste Framework Directive, Annex III - Waste - Hazardous Properties
reaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4- hydroxynaphthalene-2-sulfonic acid, Na/K salt; 7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2- sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)- 2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2- sulfonic acid, Na/K salt
EC Inventory
reaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt
SCARLET DER 8107
C&L Inventory
SCARLET DER 8107
SCARLET DER 8107
REACH pre-registration
7-amino-3,8-bis-[4-(2-sulfoksietilsulfonil)-2-sulfofenilazo]-4-hidroksinaftalen-2-sulfonrūgšties, Na/K druskos (lt)
C&L Inventory
7-amino-3,8-bis-[4-(2-sulfoksietilsulfonil)-2-sulfofenilazo]-4-hidroksinaftalen-2-sulfonska kiselina, Na/K sol (hr)
C&L Inventory
7-amino-3,8-bis-[4-(2-sulfoksietilsulfonil)-2-sulfofenilazo]-4-hidroksinaftalīn-2-sulfoskābe, Na/K sāls (lv)
C&L Inventory
7-amino-3,8-bis-[4-(2-sulfoksüetüülsulfonüül)-2-sulfofenüülaso]-4-hüdroksünaftaleen-2-sulfoonhappe naatrium-kaaliumsoola segu (et)
C&L Inventory
7-amino-3,8-bis-[4-(2-sulfoksüetüülsulfonüül)fenüülaso]-4-hüdroksünaftaleen-2-sulfoonhappe naatrium-kaaliumsoola, (et)
C&L Inventory
7-amino-3,8-bis-[4-(2-sulfoxietylsulfonyl)-2-sulfofenylazo]-4-hydroxinaftalen-2-sulfonsyra, Na/K-salt (sv)
C&L Inventory
7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalen-2-sulfonsyre, Na/K-salt (da)
C&L Inventory
7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt (mt)
C&L Inventory
7-Amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalin-2-sulfonsäure, Na-/K-Salz (de)
C&L Inventory
7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalen-2-sulfonsyre, Na/K-salt (da)
C&L Inventory
7-amino-3,8-bis[4-(2-sulfoksyetylsulfonyl)-2-sulfofenylazo]-4-hydroksynaftalen-2-sulfonsyre, Na/K-salt (no)
C&L Inventory
7-amino-3,8-bis[4-(2-sulfoxyethylsulfonyl)-2-sulfofenylazo]-4-hydroxynaftaleen-2-sulfonzuur, Na/K-zout (nl)
C&L Inventory
7-amino-3,8-bisz-[4-(2-szulfoxietilszulfonil)-2-szulfofenilazo]-4-hidroxinaftalin-2-szulfonsav Na/K sói keveréke (hu)
C&L Inventory
7-amino-3,8-bisz[4-(2-szulfoxietilszulfonil)fenilazo]-4-hidroxinaftalin-2-szulfonsav Na/K sói (hu)
C&L Inventory
7-amino-3,8bis-[4-(2-sulfoksietyylisulfonyyli)-2-sulfofenylatso]-4-hydroksinaftaleeni-2-sulfonihappo, Na/K-suola (fi)
C&L Inventory
7-amino-3-[4-(2-sulfoksietilsulfonil)fenilazo]-4-hidroksi-8-[4-(2-sulfoksiethilsulfonil)-2-sulfofenilazo]naftalen-2-sulfonska kiselina, Na/K sol (hr)
C&L Inventory
7-amino-3-[4-(2-sulfoksietilsulfonil)fenilazo]-4-hidroksi-8-[4-(2-sulfoksietilsulfonil)-2-sulfofenilazo]naftalen-2-sulfonrūgšties, Na/K druskos (lt)
C&L Inventory
7-amino-3-[4-(2-sulfoksietilsulfonil)fenilazo]-4-hidroksi-8-[4-(2-sulfoksietilsulfonil)-2-sulfofenilazo]naftalīn-2-sulfoskābe, Na/K sāls (lv)
C&L Inventory
7-amino-3-[4-(2-sulfoksietyylisulfonyyli)fenylatso]-4-hydroksi-8-[4-(2-sulfoksietyylisulfonyyli)-2-sulfofenylatso]naftaleeni-2-sulfonihappo, Na/K-suola (fi)
C&L Inventory
7-amino-3-[4-(2-sulfoksyetylsulfonyl)fenylazo]-4-hydroksy-8-[4-(2-sulfoksyetylsulfonyl)-2-sulfofenylazo]naftalen-2-sulfonsyre, Na/K-salt (no)
C&L Inventory
7-amino-3-[4-(2-sulfoksüetüülsulfonüül)fenüülaso]-4-hüdroksü-8-[4-(2-sulfoksüetüülsulfonüül)-2-sulfofenüülaso]naftaleen-2-sulfoonhappe naatrium-kaaliumsoola, (et)
C&L Inventory
7-amino-3-[4-(2-sulfoxietylsulfonyl)fenylazo]-4-hydroxi-8-[4-(2-sulfoxietylsulfonyl)-2-sulfofenylazo]naftalen-2-sulfonsyra, Na/K-salt (sv)
C&L Inventory
7-amino-3-[4-(2-sulfoxyethylsulfonyl)fenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfofenylazo]naftaleen-2-sulfonzuur, Na/K-zout (nl)
C&L Inventory
7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalen-2-sulfonsyre, Na/K-salt (da)
C&L Inventory
7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt (mt)
C&L Inventory
7-Amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalin-2-sulfonsäure, Na-/K-Salz, (de)
C&L Inventory
7-amino-3-[4-(2-szulfoxietiszulfonil)fenilazo]-4-hidroxi-8-[4-(2-szulfoxietilszulfonil)-2-szulfofenilazo]naftalin-2-szulfonsav Na/K sói (hu)
C&L Inventory
7-amino-8-[4-(2-sulfoksietilsulfonil)-fenilazo]-4-hidroksi-3-[4-(2-sulfoksietilsulfonil)-2-sulfofenilazo]naftalen-2-sulfonrūgšties, Na/K druskos (lt)
C&L Inventory
7-amino-8-[4-(2-sulfoksietilsulfonil)-fenilazo]-4-hidroksi-3-[4-(2-sulfoksietilsulfonil)-2-sulfofenilazo]naftalen-2-sulfonska kiselina, Na/K sol (hr)
C&L Inventory
7-amino-8-[4-(2-sulfoksietilsulfonil)-fenilazo]-4-hidroksi-3-[4-(2-sulfoksietilsulfonil)-2-sulfofenilazo]naftalīn-2-sulfoskābe, Na/K sāls (lv)
C&L Inventory
7-amino-8-[4-(2-sulfoksietyylisulfonyyli)fenylatso]-4-hydroksi-3-[4-(2-sulfoksietyylisulfonyyli)-2-sulfofenylatso]naftaleeni-2-sulfonihappo, Na/K-suola (fi)
C&L Inventory
7-amino-8-[4-(2-sulfoksyetylsulfonyl)fenylazo]-4-hydroksy-3-[4-(2-sulfoksyetylsulfonyl)-2-sulfofenylazo]naftalen-2-sulfonsyre, Na/K-salt (no)
C&L Inventory
7-amino-8-[4-(2-sulfoksüetüülsulfonüül)-fenüülaso]-4-hüdroksü-3-[4-(2-sulfoksüetüülsulfonüül)-2-sulfofenüülaso]naftaleen-2-sulfoonhappe naatrium-kaaliumsoola, (et)
C&L Inventory
7-amino-8-[4-(2-sulfoxietylsulfonyl)-fenylazo]-4-hydroxi-3-[4-(2-sulfoxietylsulfonyl)-2-sulfofenylazo]naftalen-2-sulfonsyra, Na/K-salt (sv)
C&L Inventory
7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt (mt)
C&L Inventory
7-amino-8-[4-(2-sulfoxyethylsulfonyl)fenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfofenylazo]naftaleen-2-sulfonzuur, Na/K-zout (nl)
C&L Inventory
7-amino-8-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalen-2-sulfonsyre, Na/K-salt og (da)
C&L Inventory
7-Amino-8-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalin-2-sulfonsäure, Na-/K-Salz und (de)
C&L Inventory
7-amino-8-[4-(2-szulfoxietiszulfonil)fenilazo]-4-hidroxi-3-[4-(2-szulfoxietilszulfonil)-2-szulfofenilazo]naftalin-2-szulfonsav Na/K sói (hu)
C&L Inventory
7-амино-3,8-бис-[4-(2-сулфоксиетилсулфонил)-2-сулфофенилазо]-4-хидроксинафтален-2-сулфонова киселина, Na/K сол (bg)
C&L Inventory
7-амино-3-[4-(2-сулфоксиетилсулфонил) фенилазо]-4-хидрокси-8-[4-(2-сулфоксиетилсулфонил)-2-сулфофенилазо]нафтален-2-сулфонова киселина, Na/K сол (bg)
C&L Inventory
7-амино-8-[4-(2-сулфоксиетилсулфонил)-фенилазо]-4-хидрокси-3-[4-(2-сулфоксиетилсулфонил)-2-сулфофенилазо] нафтален-2-сулфонова киселина, Na/K сол (bg)
C&L Inventory
acid 7-amino-3,8-bis-[4-(2-sulf-oxi-etilsulfonil)-2-sulfofenilazo]-4-hidroxinaftalin-2-sulfonic, sare de Na/K (ro)
C&L Inventory
acid 7-amino-3-[4-(2-sulf-oxi-etilsulfonil)fenilazo]-4-hidroxi-8-[4-(2-sulf-oxie-tilsulfonil)-2-sulfofenilazo]naftalin-2-sulfonic, sare de Na/K (ro)
C&L Inventory
acid 7-amino-8-[4-(2-sulf-oxi-etilsulfonil)-fenilazo]-4-hidroxi-3-[4-(2-sulf-oxi-etilsulfonil)-2-sulfofenilazo]naftalin-2-sulfonic, sare de Na/K (ro)
C&L Inventory
acide 7-amino-3,8-bis-[4-(2-sulfoxyéthylsulfonyl)-2-sulfophénylazo]-4-hydroxynaphtalène-2-sulfonique, sel Na/Kt (fr)
C&L Inventory
acide 7-amino-3-[4-(2-sulfoxyéthylsulfonyl)phénylazo]-4-hydroxy-8-[4-(2-sulfoxyéthylsulfonyl)-2-sulfophénylazo]naphtalène-2-sulfonique, sel Na/K (fr)
C&L Inventory
acide 7-amino-8-[4-(2-sulfoxyéthylsulfonyl)-phénylazo]-4-hydroxy-3-[4-(2-sulfoxyéthylsulfonyl)-2-sulfophénylazo]naphtalène-2-sulfonique, sel Na/K (fr)
C&L Inventory
amestec de: acid 7-amino-3,8-bis-[4-(2-sulf-oxi-etilsulfonil)fenilazo]-4-hidroxinaftalin-2-sulfonic, sare de Na/K (ro)
C&L Inventory
Blanding af: (da)
C&L Inventory
blanding av: 7-amino-3,8-bis[4-(2-sulfoksyetylsulfonyl)fenylazo]-4-hydroksynaftalen-2-sulfonsyre, Na/K-salt (no)
C&L Inventory
draselno-sodná soľ kyseliny 7-amino-4-hydroxy-3,8-bis-[4-(2-sulfoxyetylsulfonyl)-2-sulfofenyldiazenyl]naftalén-2-sulfónovej (sk)
C&L Inventory
draselno-sodná soľ kyseliny 7-amino-4-hydroxy-3-[4-(2-sulfoxyetylsulfonyl)fenyldiazenyl]-8-[4-(2-sulfoxyetylsulfonyl)-2-sulfofenyldiazenyl]naftalén-2-sulfónovej (sk)
C&L Inventory
draselno-sodná soľ kyseliny 7-amino-4-hydroxy-8-[4-(2-sulfoxyetylsulfonyl)fenyldiazenyl]-3-[4-(2-sulfoxyetylsulfonyl)-2-sulfofenyldiazenyl]naftalén-2-sulfónovej (sk)
C&L Inventory
Een mengsel van: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)fenylazo]-4-hydroxynaftaleen-2-sulfonzuur, Na/K-zout (nl)
C&L Inventory
En blandning av 7-amino-3,8-bis-[4-(2-sulfoxietylsulfonyl)fenylazo]-4-hydroxinaftalen-2-sulfonsyra, Na/K-salt (sv)
C&L Inventory
kwas 7-amino-3,8-bis-[4-(2-sulfoksyetylosulfonylo)-2-sulfofenyloazo]-4-hydroksynaftaleno-2-sulfonowy, sól Na/K (pl)
C&L Inventory
kwas 7-amino-3-[4-(2-sulfoksyetylosulfonylo)fenyloazo]-4-hydroksy-8-[4-(2-sulfoksyetylosulfonylo)-2-sulfofenyloazo]naftaleno-2-sulfonowy, sól Na/K (pl)
C&L Inventory
kwas 7-amino-8-[4-(2-sulfoksyetylosulfonylo)-fenyloazo]-4-hydroksy-3-[4-(2-sulfoksyetylosulfonylo)-2-sulfofenyloazo]naftaleno-2-sulfonowy, sól Na/K (pl)
C&L Inventory
Maisījums: 7-amino-3,8-bis-[4-(2-sulfoksietilsulfonil)fenilazo]-4-hidroksinaftalīn-2-sulfoskābe, Na/K sāls (lv)
C&L Inventory
masse de réaction de: acide 7-amino-3,8-bis-[4-(2-sulfoxyéthylsulfonyl)-2-sulfophénylazo]-4-hydroxynaphtalène-2-sulfonique, sel de sodium/potassium;acide 7-amino-3-[4-(2-sulfoxyéthylsulfonyl)phénylazo]-4-hydroxy-8-[4-(2-sulfoxyéthylsulfonyl)-2-sulfophénylazo]naphtalène-2-sulfonique, sel de sodium/potassium; acide 7-amino-8-[4-(2-sulfoxyéthylsulfonyl)-phénylazo]-4-hydroxy-3-[4-(2-sulfoxyéthylsulfonyl)-2-sulfophénylazo]naphtalène-2-sulfonique, sel de sodium/potassium; acide 7-amino-3,8-bis-[4-(2-sulfoxyéthylsulfonyl)-2-sulfophénylazo]-4-hydroxynaphtalène-2-sulfonique, sel de sodium/potassium (fr)
C&L Inventory
mezcla de: ácido 7-amino-3,8-bis-[4-(2-sulfoxietilsulfonil)fenilazo]-4-hidroxinaftaleno-2-sulfónico, sal de Na/K (es)
C&L Inventory
Mieszanina poreakcyjna związków: kwas 7-amino-3,8-bis-[4-(2-sulfoksyetylosulfonylo)fenyloazo]-4-hydroksynaftaleno-2-sulfonowy, sól Na/K (pl)
C&L Inventory
miscela di: sale di Na/K dell’acido 7-ammino-3,8-bis-[4-(2-solfossietilsolfonil)fenilazo]4-idrossinaftalene-2-solfonico, sale di Na/K dell’acido 7-ammino-3-[4-(2-solfossietilsolfonil)fenilazo]4-idrossi-8-[4-(2-solfossietilsolfonil)-2-solfofenilazo]naftalene-2-solfonico, (it)
C&L Inventory
mistura de: sal de Na/K do ácido 7-amino-3,8-bis[4-(2-sulfoxietilsulfonil)fenilazo]-4-hidroxinaftaleno-2-sulfónico (pt)
C&L Inventory
mišinys: 7-amino-3,8-bis-[4-(2-sulfoksietilsulfonil)fenilazo]-4-hidroksinaftalen-2-sulfonrūgšties, Na/K druskos (lt)
C&L Inventory
Mείγμα από: άλας με Na/K του 7-αμινο-3,8-δις-[4-(2-σουλφοξυαιθυλοσουλφονυλο)-φαινυλαζω]-4-υδροξυναφθαλινο-2-σουλφονικού οξέος (el)
C&L Inventory
Na/K sol 7-amino-3,8-bis-[4-(2-sulfoksietilsulfonil)-2-sulfofenilazo]-4-hidroksinaftalen-2-sulfonska kislina (sl)
C&L Inventory
Na/K sol 7-amino-3-[4-(2-sulfoksietilsulfonil)fenilazo]-4-hidroksi-8-[4-(2-sulfoksietilsulfonil)-2-sulfofenilazo]naftalen-2-sulfonska kislina (sl)
C&L Inventory
Na/K sol 7-amino-8-[4-(2-sulfoksietilsulfonil)fenilazo]-4-hidroksi-3-[4-(2-sulfoksietilsulfonil)-2-sulfofenilazo]naftalen-2-sulfonska kislina (sl)
C&L Inventory
Na/K soli kyseliny 7- amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfofenylazo]-4-hydroxynaftalen- 2-sulfonové (cs)
C&L Inventory
Na/K soli kyseliny 7- amino-3-[4-(2-sulfoxyethylsulfonyl) fenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfofenylazo]naftalen- 2-sulfonové (cs)
C&L Inventory
Na/K soli kyseliny 7- amino-8-[4-(2-sulfoxyethylsulfonyl)-fenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfofenylazo]naftalen- 2-sulfonové (cs)
C&L Inventory
Reaction mass aus 7-Amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalin-2-sulfonsäure, Na-/K-Salz, (de)
C&L Inventory
reakcijska smjesa: 7-amino-3,8-bis-[4-(2-sulfoksietilsulfonil)fenilazo]-4-hidroksinaftalen-2- (hr)
C&L Inventory
reakčná zmes zložená z týchto látok: draselno-sodná soľ kyseliny 7-amino-4-hydroxy-3,8-bis[4-(2-sulfoxyetylsulfonyl)fenyldiazenyl]naftalén-2-sulfónovej (sk)
C&L Inventory
reakční směs: Na/K soli kyseliny 7- amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl) fenylazo]-4-hydroxynaftalen- 2-sulfonové (cs)
C&L Inventory
sal de Na/K do ácido 7-amino-3,8-bis[4-(2-sulfoxietilsulfonil)-2-sulfofenilazo]-4-hidroxinaftaleno-2-sulfónico (pt)
C&L Inventory
sal de Na/K do ácido 7-amino-3-[4-(2-sulfoxietilsulfonil)fenilazo]-4-hidroxi-8-[4-(2-sulfoxietilsulfonil)-2-sulfofenilazo]naftaleno-2-sulfónico (pt)
C&L Inventory
sal de Na/K do ácido 7amino-8-[4-(2-sulfoxietilsulfonil)fenilazo]-4-hidroxi-3-[4-(2-sulfoxietilsulfonil)-2-sulfofenilazo]naftaleno-2-sulfónico (pt)
C&L Inventory
sale di Na/K dell’acido 7-ammino-3,8-bis-[4-(2-solfossietilsolfonil)-2-solfofenilazo]-4-idrossinaftalene-2-solfonico (it)
C&L Inventory
sale di Na/K dell’acido 7-ammino-8-[4-(2-solfossietilsolfonil)-fenilazo]-4-idrossi-3-[4-(2-solfossietilsolfonil)-2-solfofenilazo]naftalene-2-solfonico e (it)
C&L Inventory
seos: 7-amino-3,8bis-[4-(2-sulfoksietyylisulfonyyli)fenylatso]-4-hydroksinaftaleeni-2-sulfonihappo, Na/K-suola (fi)
C&L Inventory
sulfonska kiselina, Na/K sol (hr)
C&L Inventory
Taħlita ta’: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt (mt)
C&L Inventory
zmes: Na/K sol 7-amino-3,8-bis-[4-(2-sulfoksietilsulfonil)fenilazo]-4-hidroksinaftalen-2-sulfonska kislina (sl)
C&L Inventory
ácido 7-amino-3,8-bis-[4-(2-sulfoxietilsulfonil)-2-sulfofenilazo]-4-hidroxinaftaleno-2-sulfónico, sal de Na/K (es)
C&L Inventory
ácido 7-amino-3-[4-(2-sulfoxietilsulfonil)fenilazo]-4-hidroxi-8-[4-(2-sulfoxietilsulfonil)-2-sulfofenilazo]naftaleno-2-sulfónico, sal de Na/K (es)
C&L Inventory
ácido 7-amino-8-[4-(2-sulfoxietilsulfonil)-fenilazo]-4-hidroxi-3-[4-(2-sulfoxietilsulfonil)-2-sulfofenilazo]naftaleno-2-sulfónico, sal de Na/K (es)
C&L Inventory
άλας με Na/K του 7-αμινο-3,8-δις-[4-(2-σουλφοξυαιθυλοσουλφονυλο)-2-σουλφοφαινυλαζω]-4-υδροξυναφθαλινο-2-σουλφονικού οξέος (el)
C&L Inventory
άλας με Na/K του 7-αμινο-3-[4-(2-σουλφοξυαιθυλοσουλφονυλο)-φαινυλαζω]-4-υδροξυ-8-[4-(2-σουλφοξυαιθυλοσουλφονυλο)-2-σουλφοφαινυλαζω]ναφθαλινο-2-σουλφονικού οξέος (el)
C&L Inventory
άλας με Na/K του 7-αμινο-8-[4-(2-σουλφοξυαιθυλοσουλφονυλο)-φαινυλαζω]-4-υδροξυ-3-[4-(2-σουλφοξυαιθυλοσουλφονυλο)-2-σουλφοφαινυλαζω]ναφθαλινο-2-σουλφονικού οξέος και (el)
C&L Inventory
реакционна маса от: 7-амино-3,8-бис-[4-(2-сулфоксиетилсулфонил)фенилазо]-4-хидроксинафтален-2-сулфонова киселина, Na/K сол (bg)
C&L Inventory
2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-, coupled with diazotized 2-[(4-aminophenyl)sulfonyl]ethyl hydrogen sulfate and diazotized 2-amino-5-[[2-(sulfooxy)ethyl]sulfonyl]benzenesulfonic acid, potassium sodium salts
Other
7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K saltreaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt
Registration dossier
octapotassium octasodium 7-amino-4-hydroxy-3,8-bis(2-{2-sulfo-4-[2-(sulfooxy)ethanesulfonyl]phenyl}diazen-1-yl)naphthalene-2-sulfonate 7-amino-4-hydroxy-3,8-bis(2-{4-[2-(sulfooxy)ethanesulfonyl]phenyl}diazen-1-yl)naphthalene-2-sulfonate 7-amino-4-hydroxy-3-(2-{2-sulfo-4-[2-(sulfooxy)ethanesulfonyl]phenyl}diazen-1-yl)-8-(2-{4-[2-(sulfooxy)ethanesulfonyl]phenyl}diazen-1-yl)naphthalene-2-sulfonate 7-amino-4-hydroxy-8-(2-{2-sulfo-4-[2-(sulfooxy)ethanesulfonyl]phenyl}diazen-1-yl)-3-(2-{4-[2-(sulfooxy)ethanesulfonyl]phenyl}diazen-1-yl)naphthalene-2-sulfonate
Registration dossier, Other
Reaction mass of 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt and 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt and 7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt and 7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt
C&L Inventory
Reaction mass of potassium sodium 7-amino-4-hydroxy-3,8-bis(2-{2-sulfo-4-[2-(sulfooxy)ethanesulfonyl]phenyl}diazen-1-yl)naphthalene-2-sulfonate, 7-amino-4-hydroxy-3,8-bis(2-{4-[2-(sulfooxy)ethanesulfonyl]phenyl}diazen-1-yl)naphthalene-2-sulfonate, 7-amino-4-hydroxy-3-(2-{2-sulfo-4-[2-(sulfooxy)ethanesulfonyl]phenyl}diazen-1-yl)-8-(2-{4-[2-(sulfooxy)ethanesulfonyl]phenyl}diazen-1-yl)naphthalene-2-sulfonate, 7-amino-4-hydroxy-8-(2-{2-sulfo-4-[2-(sulfooxy)ethanesulfonyl]phenyl}diazen-1-yl)-3-(2-{4-[2-(sulfooxy)ethanesulfonyl]phenyl}diazen-1-yl)naphthalene-2-sulfonate
Registration dossier
reaction mass of: 2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-8-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-3-[2-[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, Na/K salt and 7-amino-4-hydroxy-3,8-bis((E)-(4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)diazenyl) naphthalene-2-sulfonic acid, Na/K salt and 2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-3-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-8-[2-[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, Na/K salt and 6,6'-((1E,1'E)-(2-amino-5-hydroxy-7-sulfonaphthalene-1,6-diyl)bis(diazene-2,1-diyl))bis(3-((2-(sulfooxy)ethyl)sulfonyl)benzenesulfonic acid) Na/K salt
Registration dossier
reaction mass of: 2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-8-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-3-[2-[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, Na/K salt and 7-amino-4-hydroxy-3,8-bis((E)-(4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)diazenyl) naphthalene-2-sulfonic acid, Na/K salt and 2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-3-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-8-[2-[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, Na/K salt and 6,6'-((1E,1'E)-(2-amino-5-hydroxy-7-sulfonaphthalene-1,6-diyl)bis(diazene-2,1-diyl))bis(3-((2-(sulfooxy)ethyl)sulfonyl)benzenesulfonic acid) Na/K salt
Registration dossier
reaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt
C&L Inventory
reaction mass of:7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt
Registration dossier
Reactive Scarlet F07-0522
Registration dossier
214362-06-8
CAS number
C&L Inventory, Other, CAD - Chemical Agents Directive, Art. 2(b)(i) - Hazardous Agents, Construction Product Regulation - Annex I (3) - Hazardous Substances, Construction Product Regulation - Art. 6(5) - SDS and Declaration, EU Ecolabels - Restrictions for Hazardous Substances/Mixtures, Active Implantable Medical Devices Directive - Hazardous Substances, In Vitro Diagnostic Medical Devices Directive - Hazardous Substances, , Marine Environmental Policy Framework Directive - Hazardous Substances, Medical Devices Directive - Hazardous Substances, Medical Devices Regulation - Hazardous Substances, General Product Safety Directive - Hazardous Substances, Workplace Signs - minimum requirements & signs on containers and pipes, Safety and Health of Workers at Work Directive - Hazardous Substances, Waste Framework Directive, Annex III - Waste - Hazardous Properties
611-144-00-4
Index number
C&L Inventory

Scientific properties

Physical and chemical properties

This section provides physicochemical information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Appearance/physical state / colour

Study results
  • 3 studies submitted
  • 2 studies processed
C Physical state at 20°C and 1013 hPa
Solid (100%) [2]
C Form
Powder (100%) [2]
C Substance type
Organic (100%) [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Physical state at 20°C and 1013 hPa
Solid (100%)
Form
Solid: particulate/powder (100%)
Colour
brown (50%), red (50%)
Colour Intensity
dark (100%)

Melting/freezing point

Study results
  • 3 studies submitted
  • 2 studies processed
R Melting / freezing point
400 °C [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Melting / freezing point at 101 325 Pa
400 °C

Boiling point

Study results
  • 3 studies submitted
  • 2 studies processed
R Boiling point
735 °C @ 101.3 kPa [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Boiling point at 101 325 Pa
735 °C

Density

Study results
  • 3 studies submitted
  • 2 studies processed
R Relative density
1.81 @ 20 °C [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Relative density at 20°C
1.81

Vapour pressure

Study results
  • 3 studies submitted
  • 2 studies processed
R Vapour pressure
0 Pa @ 25 °C [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Vapour pressure
0 Pa @ 25 °C

Partition coefficient

Study results
  • 3 studies submitted
  • 2 studies processed
R Log Pow
-4.5 @ 20 °C and pH 7 [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Log Kow (Log Pow)
-4.5 @ 20 °C

Water solubility

Study results
  • 3 studies submitted
  • 2 studies processed
R Water solubility (mass/vol.)
277 g/L @ 20 °C and pH 4.6 [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Water solubility
277 g/L @ 20 °C

Solubility in organic solvents / fat solubility

Data not provided by the registrant

Surface tension

Study results
  • 3 studies submitted
  • 2 studies processed
R Surface tension
68.4 mN/m @ 1 g/L and 20 °C [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Surface tension at 20 °C
68.4 mN/m @ 1 000 mg/L

Flash point

Study results
  • 3 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 1
Data waiving
Not feasible
Sci. unjustified 2
Exposure cons.
Other
Summaries
  • 2 summaries submitted
  • 0 summaries processed

No automatically processable data submitted

Auto flammability

Study results
  • 3 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Autoflammability / self-ignition at 101 325 Pa
400 °C

Flammability

Study results
  • 3 studies submitted
  • 2 studies processed
C Interpretation of results
GHS criteria not met (100%) [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Flammability
Not classified (100%)

Explosiveness

Study results
  • 3 studies submitted
  • 2 studies processed
C Interpretation of results
GHS criteria not met (100%) [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Explosiveness
Non-explosive (100%)

Oxidising

Study results
  • 3 studies submitted
  • 2 studies processed
C Interpretation of results
GHS criteria not met (100%) [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Oxidising
Non oxidising (100%)

Oxidation reduction potential

Data not provided by the registrant

pH

Data not provided by the registrant

Dissociation constant

Study results
  • 3 studies submitted
  • 2 studies processed
C Dissociating properties
Yes (100%) [2]
R Dissociation constant
-7.4 - 7.2 [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
pKa at 20 °C
-7.4

Viscosity

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible 2
Sci. unjustified
Exposure cons.
Other
Summaries
  • 2 summaries submitted
  • 0 summaries processed

No automatically processable data submitted

Environmental fate and pathways

This section provides environmental fate and pathways information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Phototransformation in air

Data not provided by the registrant

Hydrolysis

Study results
  • 3 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Half-life for hydrolysis
64.3 h @ 25 °C

Phototransformation in water

Data not provided by the registrant

Phototransformation in soil

Data not provided by the registrant

Biodegradation in water - screening tests

Study results
  • 11 studies submitted
  • 2 studies processed
C Interpretation of results
Not readily biodegradable (100%) [2]

Type of Study provided
Studies with data
Key study 2
Supporting study 6
Weight of evidence
Other 3
Data waiving
no waivers
C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Biodegradation in water
Under test conditions no biodegradation observed (100%)
Type of water
Freshwater (100%)

Biodegradation in water & sediment - simulation tests

Data not provided by the registrant

Biodegradation in soil

Study results
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons. 1
Other 1
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Bioaccumulation: aquatic / sediment

Study results
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other 1
Summaries
  • 2 summaries submitted
  • 0 summaries processed

No automatically processable data submitted

Bioaccumulation: terrestrial

Data not provided by the registrant

Adsorption/desorption

Study results
  • 3 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Koc at 20°C
506

Henrys law constant (H)

Data not provided by the registrant

Distribution modelling

Data not provided by the registrant

Ecotoxicological information

This section provides ecotoxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Predicted No-Effect Concentration (PNEC)

R Summaries
  • 2 summaries submitted
  • 2 summaries processed

The Predicted No-Effect Concentration (PNEC) value is the concentration of a substance below which adverse effects in the environment are not expected to occur. Please note that when more than one summary is provided, PNEC values may refer to constituents of the substance and not to the substance as a whole. More detailed information is available in the dossiers.

Hazard for Aquatic Organisms
Freshwater 100 µg/L (1)
Intermittent releases (freshwater) 1 mg/L (1)
Marine water 10 µg/L (1)
Intermittent releases (marine water) No hazard identified (1)
Sewage treatment plant (STP) 100 mg/L (1)
Sediment (freshwater) 5.42 mg/kg sediment dw (1)
Sediment (marine water) 542 µg/kg sediment dw (1)
Hazard for Air
Air No hazard identified (2)
Hazard for Terrestrial Organism
Soil 1.02 mg/kg soil dw (1)
Hazard for Predators
Secondary poisoning No potential for bioaccumulation (2)

Short–term toxicity to fish

Study results
  • 3 studies submitted
  • 2 studies processed
P/RResults
LC50 (4 days) 100 mg/L [2]
LC50 (72 h) 100 mg/L [2]
LC50 (48 h) 100 mg/L [2]
LC50 (24 h) 100 mg/L [2]
LC0 (4 days) 100 mg/L [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
Summaries
  • 2 summaries submitted
  • 0 summaries processed

No automatically processable data submitted

Long–term toxicity to fish

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons. 2
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Short–term toxicity to aquatic invertebrates

Study results
  • 3 studies submitted
  • 2 studies processed
P/RResults
EC50 (48 h) 100 mg/L [2]
EC50 (24 h) 100 mg/L [2]
EC100 (48 h) 100 mg/L [2]
NOEC (48 h) 100 mg/L [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
Summaries
  • 2 summaries submitted
  • 0 summaries processed

No automatically processable data submitted

Long–term toxicity to aquatic invertebrates

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons. 2
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to aquatic algae and cyanobacteria

Study results
  • 3 studies submitted
  • 2 studies processed
P/RResults
EC50 (72 h) 100 mg/L [2]
NOEC (72 h) 100 mg/L [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
EC50 for freshwater algae
100 mg/L
EC10 or NOEC for freshwater algae
100 mg/L

Toxicity to aquatic plants other than algae

Data not provided by the registrant

Toxicity to microorganisms

Study results
  • 3 studies submitted
  • 2 studies processed
P/RResults
IC50 (3 h) 1 g/L [2]
NOEC (3 h) 1 g/L [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
EC50 for microorganisms
1 g/L
EC10 or NOEC for microorganisms
1 g/L

Sediment toxicity

Data not provided by the registrant

Endocrine disrupter testing in aquatic vertebrates – in vivo

Data not provided by the registrant

Toxicity to terrestrial macroorganisms except arthropods

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons. 2
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to terrestrial arthropods

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons. 2
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to terrestrial plants

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons. 2
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to soil microorganisms

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons. 2
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to birds

Data not provided by the registrant

Toxicity to mammals

Data not provided by the registrant

Toxicological information

This section provides toxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Derived No- or Minimal Effect Level (DN(M)EL)

M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed

The derived no- or minimum effect level (DN(M)EL) is the level of exposure above which a human should not be exposed to a substance. Please note that when more than one summary is provided, DN(M)EL values may refer to constituents of the substance and not to the substance as a whole. More detailed information is available in the dossiers.

Data for WORKERS
INHALATION Exposure Threshold Most sensitive study
Systemic Effects
Long-term: (DNEL) 6.58 mg/m³ repeated dose toxicity
Acute /short term: No hazard identified
Local Effects
Long-term: No hazard identified
Acute /short term: No hazard identified
DERMAL Exposure Threshold Most sensitive study
Systemic Effects
Long-term: (DNEL) 933 µg/kg bw/day repeated dose toxicity
Acute /short term: No hazard identified
Local Effects
Long-term: No hazard identified
Acute /short term: No hazard identified
EYE Exposure
Medium hazard (no threshold derived)
Data for the GENERAL POPULATION
INHALATION Exposure Threshold Most sensitive study
Systemic Effects
Long-term: (DNEL) 1.16 mg/m³ repeated dose toxicity
Acute /short term: No hazard identified
Local Effects
Long-term: No hazard identified
Acute /short term: No hazard identified
DERMAL Exposure Threshold Most sensitive study
Systemic Effects
Long-term: (DNEL) 333 µg/kg bw/day repeated dose toxicity
Acute /short term: No hazard identified
Local Effects
Long-term: No hazard identified
Acute /short term: No hazard identified
ORAL Exposure Threshold Most sensitive study
Systemic Effects
Long-term: (DNEL) 333 µg/kg bw/day repeated dose toxicity
Acute /short term: No hazard identified
EYE Exposure
Medium hazard (no threshold derived)

Toxicokinetics, metabolism, and distribution

Study results
Study data: basic toxicokinetics
  • 3 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: basic toxicokinetics
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 1
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
Study data: dermal absorption
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: dermal absorption
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Bioaccumulation potential:
Low bioaccumulation potential
Absorption values
Oral: 10 %
Dermal: 10 %
Inhalation: 10 %

Acute toxicity

Study results
oral
  • 3 studies submitted
  • 2 studies processed
P/RResults
LD50 2 000 mg/kg bw (rat) [2]
M/CInterpretations of results
GHS criteria not met [2]

Type of Study provided
oral
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
inhalation
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

inhalation
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons. 1
Other 1
dermal
  • 3 studies submitted
  • 2 studies processed
P/RResults
LD50 2 000 mg/kg bw (rat) [2]
M/CInterpretations of results
GHS criteria not met [2]

dermal
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
other routes
  • 0 studies submitted
  • 0 studies processed

No data available

other routes
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Oral route:
No adverse effect observed LD50 2 000 mg/kg bw
Dermal route:
No adverse effect observed LD50 2 000 mg/kg bw

Irritation / corrosion

Study results
Study data: skin
  • 5 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: skin
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
Not feasible
Sci. unjustified 2
Exposure cons.
Other
Study data: eye
  • 5 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: eye
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
Not feasible
Sci. unjustified 2
Exposure cons.
Other
M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Skin
No adverse effect observed (not irritating)
Eye
Adverse effect observed (irritating)
Respiratory
No study available

Sensitisation

Study results
Study data: skin
  • 5 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: skin
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
Not feasible
Sci. unjustified 2
Exposure cons.
Other
Study data: respiratory
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: respiratory
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Skin sensitisation
No adverse effect observed (not sensitising)
Respiratory sensitisation
No study available

Repeated dose toxicity

Study results
Study data: oral
  • 5 studies submitted
  • 2 studies processed
P/RResults
NOAEL (rat): 200 - 1 000 mg/kg bw/day [2]
NOEL (rat): 200 mg/kg bw/day [2]

Type of Study provided
Study data: oral
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 2
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Study data: inhalation
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Study data: inhalation
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 2
Exposure cons.
Other
Study data: dermal
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Study data: dermal
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 2
M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Oral route - systemic effects:
Adverse effect observed NOAEL 200 mg/kg bw/day (subacute, rat)

Genetic toxicity

Study results
Study data: in vitro
  • 8 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: in vitro
Studies with data
Key study 6
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Study data: in vivo
  • 3 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: in vivo
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Toxicity - InVitro
No adverse effect observed (negative)
Toxicity - InVivo
No adverse effect observed (negative)

Carcinogenicity

Data not provided by the registrant

Toxicity to reproduction

Study results
Study data: reproduction
  • 5 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: reproduction
Studies with data
Key study 3
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 2
Exposure cons.
Other
Study data: developmental
  • 6 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: developmental
Studies with data
Key study 3 2
Supporting study 1
Weight of evidence
Other
Data waiving
no waivers
Study data: other studies
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: other studies
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Effect on fertility
Oral route:
No adverse effect observed NOAEL 1 000 mg/kg bw/day (subacute, rat)
Effect on developmental toxicity
Oral route:
No adverse effect observed NOAEL 1 000 mg/kg bw/day (subacute, rat)

Neurotoxicity

Data not provided by the registrant

Immunotoxicity

Data not provided by the registrant

Endocrine disrupter mammalian screening - in vivo

Data not provided by the registrant